Production of 2',3'-dideoxy-2',3'-didehydronucleosides
AssigneeBristol-Myers Company
InventorsJohn E. Starrett, Jr., Muzammil M. Mansuri, John C. Martin, Carl E. Fuller, Henry G. Howell
Life of this patent
Estimating the term…
Abstract
There are disclosed novel processes for producing 2',3'-dideoxy-2'3'-didehydronucleosides, for example, 2',3'-dideoxy-2',3'-didehydrothymidine in high yields and on a large scale. The compounds so-produced are useful as antiviral agents, especially as agents effective against the human immunodeficiency viruses (HIV).
Claims1
A process for producing a 2',3'-dideoxy-2',3'-didehydronucleoside represented by the formula ##STR24## wherein B is a member selected from the group of bases consisting of uracil, and 5-methyluracil comprising the steps of:
- (a) reacting a starting ribonucleoside represented by the formula ##STR25## with an acyloxyisobutyryl bromide in a polar solvent under anhydrous conditions at an elevated temperature of about 75.degree.-100.degree. C. for about 1-3 hrs to obtain a reactive intermediate represented by the formulas ##STR26## wherein R represents the acyloxyisbutyryl group and R' represents the acyl group of the acyloxyisobutyryl bromide;
- (b) subjecting the intermediate from step (a) to an elimination reaction by treatment of said intermediate in an aprotic polar solvent with Zn/Cu reagent. ##STR27## (c) deprotecting the 5'--O-protecting group in the intermediate from step (b) by treatment of said intermediate with a mild base to give derived 2',3'-dideoxy-2',3'-didehydronucleoside.
Dependencies are inferred from the claim text.